Articles

"DiSight Medical" Cui Di: Solving Pain Points in Fundus and Microsurgery with High-Precision Ophthalmic Surgical Robots | Linear Capital Portfolio Interview Series

"DiSight Medical" Cui Di: Solving Pain Points in Fundus and Microsurgery with High-Precision Ophthalmic Surgical Robots | Linear Capital Portfolio Interview Series

In July 2023, Linear Capital portfolio company Hangzhou Disight Medical Biotechnology Co., Ltd. successfully performed a subretinal thrombolysis procedure for treating macular hemorrhage at Zhejiang Provincial People's Hospital using its "Disight MicroEdge" ophthalmic surgical robot — **the first such procedure in Asia**. The company achieved its clinical milestone just two years after founding, and completed [three rounds of financing](https://mp.weixin.qq.com/s/...) in 2023 alone.

Linear Capital-led angel-round portfolio company Xinkong Intelligent announced the completion of a nearly RMB 100 million Series B funding round.

Linear Capital-led angel-round portfolio company Xinkong Intelligent announced the completion of a nearly RMB 100 million Series B funding round.

Recently, **Xinkong Intelligent, a Linear Capital seed-round portfolio company and leader in intelligent production-line infrastructure, announced the completion of a nearly RMB 100 million Series B funding round.** This round was led by Xiyu Capital, with follow-on investment from Yima Capital (Hundsun Electronics), and Index Capital served as the exclusive financial advisor.